HKEx Stock Code: 01093English|繁體|简体

In 2018 interim results

  • Sales of approximately HK$10,787 million, representing a 49.8% growth (or a 37.6% growth on a constant currency basis) year-on-year
  • Profit attributable to shareholders of approximately HK$1,853 million, representing a 41.1% growth (or a 29.7% growth on a constant currency basis) year-on-year.

Highlight - 2018 Interim

Revenue
HK$10,787 mn
Attributable profit
HK$1,853 mn
Basic earnings per share
HK29.68 cents

Corporate Governance

Corporate Governance

Financial Calendar

NOV
19
NOV
19
AUG
20
AUG
20
May
25
May
25
May
25
Mar
19

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2018 CSPC Pharmaceutical Group Limited. All Rights Reserved.